Simplex Trading, LLC Virios Therapeutics, Inc. Transaction History

Simplex Trading, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	SELL	$0.46 - $0.9 $6,366 - $12,456	-13,841 Reduced 44.34%	17,372 $9,000
Q3 2023 Nov 01, 2023	BUY	$0.86 - $2.42 $7,908 - $22,254	9,196 Added 41.77%	31,213 $28,000
Q2 2023 Aug 04, 2023	BUY	$0.35 - $1.94 $4,281 - $23,732	12,233 Added 125.03%	22,017 $30,000
Q1 2023 Apr 27, 2023	BUY	$0.24 - $0.44 $1,196 - $2,193	4,986 Added 103.92%	9,784 $3,000
Q4 2022 Feb 02, 2023	SELL	$0.24 - $0.39 $3,860 - $6,273	-16,086 Reduced 77.03%	4,798 $1,000
Q3 2022 Nov 04, 2022	BUY	$0.37 - $8.77 $7,727 - $183,152	20,884 New	20,884 $7,000
Q1 2022 May 02, 2022	SELL	$4.48 - $6.92 $828 - $1,280	-185 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$4.07 - $6.12 $752 - $1,132	185 New	185 $0

991K

Ticker VIRI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,330,400
Market Cap $3.12M
Description
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.